tiprankstipranks
Nucana Plc (NCNA)
NASDAQ:NCNA
US Market
Holding NCNA?
Track your performance easily

Nucana (NCNA) Stock Forecast & Price Target

1,248 Followers
See the Price Targets and Ratings of:

NCNA Financial Forecast

NCNA Earnings Forecast

Next quarter’s earnings estimate for NCNA is -$0.09 with a range of -$0.09 to -$0.09. The previous quarter’s EPS was -$0.09. NCNA beat its EPS estimate 25.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 40.82% of the time in the same period. In the last calendar year NCNA has Outperformed its overall industry.
Next quarter’s earnings estimate for NCNA is -$0.09 with a range of -$0.09 to -$0.09. The previous quarter’s EPS was -$0.09. NCNA beat its EPS estimate 25.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 40.82% of the time in the same period. In the last calendar year NCNA has Outperformed its overall industry.
No data currently available

NCNA Sales Forecast

Next quarter’s sales forecast for NCNA is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. NCNA beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 36.99% of the time in the same period. In the last calendar year NCNA has Preformed in-line its overall industry.
Next quarter’s sales forecast for NCNA is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. NCNA beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 36.99% of the time in the same period. In the last calendar year NCNA has Preformed in-line its overall industry.

Detailed List of Analyst Forecasts​

Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Oppenheimer
$25
Buy
2092.98%
Upside
Reiterated
09/16/24
Oppenheimer Sticks to Their Buy Rating for Nucana (NCNA)
William Blair
Hold
Downgraded
08/29/24
NuCana downgraded to Market Perform from Outperform at William BlairNuCana downgraded to Market Perform from Outperform at William Blair
Truist Financial
Buy
Reiterated
03/28/24
Truist Financial Sticks to Its Buy Rating for Nucana (NCNA)
TD Cowen
Hold
Assigned
03/25/24
Nucana (NCNA) Receives a Hold from TD Cowen

Best Analysts Covering Nucana

Which Analyst Should I Follow If I Want to Buy NCNA and Sell After:
1 Month
xxx
Success Rate
6/17 ratings generated profit
35%
Average Return
-3.11%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 35.29% of your transactions generating a profit, with an average return of -3.11% per trade.
3 Months
xxx
Success Rate
4/17 ratings generated profit
24%
Average Return
-15.17%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 23.53% of your transactions generating a profit, with an average return of -15.17% per trade.
1 Year
Leland GershellOppenheimer
Success Rate
2/17 ratings generated profit
12%
Average Return
-53.26%
reiterated a buy rating 4 months ago
Copying Leland Gershell's trades and holding each position for 1 Year would result in 11.76% of your transactions generating a profit, with an average return of -53.26% per trade.
2 Years
xxx
Success Rate
0/17 ratings generated profit
0%
Average Return
-77.19%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -77.19% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

NCNA Analyst Recommendation Trends

Rating
Jul 24
Aug 24
Sep 24
Oct 24
Dec 24
Strong Buy
3
2
4
4
3
Buy
1
1
1
1
1
Hold
1
2
1
1
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
5
5
6
6
5
In the current month, NCNA has received 4 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. NCNA average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

NCNA Stock Forecast FAQ

What is NCNA’s average 12-month price target, according to analysts?
Currently, no data Available
What is NCNA’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for NCNA, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is NCNA a Buy, Sell or Hold?
      Currently, no data Available
      What is Nucana Plc’s price target?
      Currently, no data Available
      What do analysts say about Nucana Plc?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of NCNA?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis